Bluebird To Cut Workforce By About 30%

bluebird bio, Inc. (BLUE), a biotech firm, said on Tuesday that it decided to trim its workforce by about 30% as part of the restructuring that the company expects to deliver savings of up to $160 million.

In December last year the company had said FDA placed its clinical program for
lovotibeglogene autotemcel gene therapy for sickle cell disease on partial clinical hold.

The company now said it plans a potential submission of a biologics license application (BLA) for lovotibeglogene autotemcel (lovo-cel) gene therapy for sickle cell disease in the first quarter of 2023.

The initiative is anticipated to cash burn in 2022 to less than $340 million, with a 35 to 40 percent reduction in operating costs anticipated by the year-end 2022, which is also expected to be reflected in the company's operating budget for 2023.

bluebird said the restructuring is expected to extend its cash runway into the first half of 2023.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Longmont Colorado -based Royal Crest Dairy is recalling 2% Chocolate Milk citing the potential to be contaminated with undeclared egg, a known allergen, the U.S. Food and Drug Administration said. The recall involves Farmer's 2% Reduced Fat Chocolate Milk Pints with the code date of AUG-22. ANI Pharmaceuticals, Inc. (ANIP) Monday announced a wider loss for the second quarter, despite a 52 percent surge in revenues. For the full year 2022, the company reiterated the adjusted earnings per share range, revenue guidance and raised Cortrophin revenue outlook. The company reported a quarterly... Shares of BioNTech SE were losing around 4 percent in the morning trading in Germany and around 5 percent in the pre-market activity on Nasdaq after the German Covid-19 vaccine maker reported sharp drop in profit and revenues for the second quarter. However, the company recorded strong growth in first-half results. Further, the company maintained BioNTech COVID-19 vaccine revenue guidance
Follow RTT